- Home
- GMTL vs PACB Comparison
GMTL vs PACB Comparison
Compare GMTL & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GMTL | PACB |
|---|---|---|
| Founded | 2021 | 2000 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 626.4M | 521.8M |
| IPO Year | 2026 | 2010 |
Fundamental Metrics
Financial Performance| Metric | GMTL | PACB |
|---|---|---|
| Price | $10.37 | $1.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $30.00 | $1.67 |
| AVG Volume (30 Days) | 203.7K | ★ 6.0M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | N/A | $12.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $11.03 | $1.09 |
| 52 Week High | $22.21 | $2.73 |
Technical Indicators
Market Signals| Indicator | GMTL | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 29.05 | 49.32 |
| Support Level | N/A | $1.31 |
| Resistance Level | $17.88 | $1.79 |
| Average True Range (ATR) | 1.24 | 0.13 |
| MACD | -0.34 | -0.01 |
| Stochastic Oscillator | 0.57 | 37.14 |
Price Performance
Historical ComparisonAbout GMTL Guardian Metal Resources PLC ADS
Guardian Metal Resources PLC focuses on metals exploration and development, with a focus on precious metals exploration in North America. The Company has one business segment, which is the exploration and evaluation of mineral resources in Nevada, USA. Its exploration projects comprise the Pilot Mountain Project, Tempiute Project, Golconda Summit Project, Stonewall Project, and Garfield Project, and the Group is the operator of the Golconda Summit Project.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.